JP2022554147A5 - - Google Patents

Info

Publication number
JP2022554147A5
JP2022554147A5 JP2022523874A JP2022523874A JP2022554147A5 JP 2022554147 A5 JP2022554147 A5 JP 2022554147A5 JP 2022523874 A JP2022523874 A JP 2022523874A JP 2022523874 A JP2022523874 A JP 2022523874A JP 2022554147 A5 JP2022554147 A5 JP 2022554147A5
Authority
JP
Japan
Prior art keywords
fingolimod
containing layer
treatment system
weight
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022523874A
Other languages
English (en)
Japanese (ja)
Other versions
JP7641279B2 (ja
JP2022554147A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/079549 external-priority patent/WO2021078761A1/en
Publication of JP2022554147A publication Critical patent/JP2022554147A/ja
Publication of JP2022554147A5 publication Critical patent/JP2022554147A5/ja
Application granted granted Critical
Publication of JP7641279B2 publication Critical patent/JP7641279B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022523874A 2019-10-24 2020-10-21 フィンゴリモドの経皮投与のための経皮治療システム Active JP7641279B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19205133 2019-10-24
EP19205133.2 2019-10-24
PCT/EP2020/079549 WO2021078761A1 (en) 2019-10-24 2020-10-21 Transdermal therapeutic system for the transdermal administration of fingolimod

Publications (3)

Publication Number Publication Date
JP2022554147A JP2022554147A (ja) 2022-12-28
JP2022554147A5 true JP2022554147A5 (enExample) 2023-10-26
JP7641279B2 JP7641279B2 (ja) 2025-03-06

Family

ID=68342821

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022523874A Active JP7641279B2 (ja) 2019-10-24 2020-10-21 フィンゴリモドの経皮投与のための経皮治療システム

Country Status (8)

Country Link
US (1) US20230233480A1 (enExample)
EP (1) EP4048247B1 (enExample)
JP (1) JP7641279B2 (enExample)
CN (1) CN114599349B (enExample)
BR (1) BR112022007369A2 (enExample)
CA (1) CA3154505A1 (enExample)
ES (1) ES2980430T3 (enExample)
WO (1) WO2021078761A1 (enExample)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7387788B1 (en) * 2003-10-10 2008-06-17 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof
CN101501088B (zh) 2006-06-06 2011-11-30 道康宁公司 有机硅丙烯酸酯混杂组合物
RU2544702C2 (ru) 2009-04-24 2015-03-20 Хенкель Корпорейшн Клеи на основе силикон-акрилового гибридного полимера
JP2013139554A (ja) 2011-11-29 2013-07-18 Dow Corning Corp シリコーンアクリレートハイブリッド組成物及び該組成物の製造方法
CA2840997A1 (en) * 2013-02-05 2014-08-05 Nitto Denko Corporation Vaccine composition for transdermal administration
CN105611917A (zh) * 2013-10-11 2016-05-25 帝国制药美国公司 局部鞘氨醇-1-磷酸酯受体激动剂制剂及其使用方法
WO2016130408A1 (en) 2015-02-09 2016-08-18 Dow Corning Corporation Multi-phase silicone acrylic hybrid visco-elastic compositions and methods of making same
CN105395530A (zh) * 2015-11-27 2016-03-16 天津医科大学总医院 芬戈莫德的新用途
CN116270551A (zh) * 2016-07-27 2023-06-23 考里安有限责任公司 通过盐至中性药物原位转化的组合物、透皮贴剂及应用
WO2018022814A1 (en) * 2016-07-27 2018-02-01 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
US20190029971A1 (en) * 2017-07-26 2019-01-31 Corium International, Inc. Transdermal delivery system with a microporous membrane having solvent-filled pores
WO2019126256A1 (en) * 2017-12-19 2019-06-27 The Johns Hopkins University Supramolecular hydrogel applications to the carotid bodies

Similar Documents

Publication Publication Date Title
CN1187049C (zh) 含有丁丙诺啡的贴片
US9717697B2 (en) Compositions and methods for the transdermal delivery of methylphenidate
JP2016502989A5 (enExample)
CA2423836A1 (en) Composition for the delivery of fentanyl
RU2014125322A (ru) Средство и способ трансдермальной доставки эстрогена
JP2010510260A5 (enExample)
JP2005528413A5 (enExample)
CA2662510A1 (en) Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy
KR0163597B1 (ko) 니트로글리세린의 경피 투여형 약제
US4971799A (en) Percutaneous-administration-type pharmaceutical preparation of nitroglycerin
CN1655772A (zh) 含有芬太尼的贴剂
JP2022554147A5 (enExample)
JP2021522187A5 (enExample)
JP2021515789A5 (enExample)
JP2021517572A5 (enExample)
JP5027373B2 (ja) エストラジオール含有貼付剤
JP3676567B2 (ja) 医療用粘着剤組成物及び医療用貼付剤
EP1547600B1 (en) Estradiol-containing patch
KR100563194B1 (ko) 펜타닐을 유효성분으로 함유하는 경피투여제제
KR100579721B1 (ko) 툴로부테롤을 함유하는 경피투여용 패취제
KR20130049353A (ko) 펜타닐을 함유하는 경피투여용 패취시스템
JP4617069B2 (ja) 貼付剤
JP2021517569A5 (enExample)
AU2011248162A1 (en) Triamcinolone acetonide formulations for treating dermatitis and psoriasis
JP2021515791A5 (enExample)